首页 / 院系成果 / 成果详情页

RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis 会议论文

编号：

2fc54a14-f387-4d1c-b284-626aa8635bb5
作者：

Cosgriff, Thomas; Yang, Lin; Alyasova, Anna; Ye, Dingwei; Karpenko, Andrey; Alekseev, Boris; Kowalyszyn, Ruben; Karyakin, Oleg; Neron, Yeni; Collins, La T.; Brechenmacher, Thomas; Lin, Chinjune; Morgan, Liza; Motzer, Robert
作者单位：

[Cosgriff, Thomas] Crescent City Res Consortium, Metairie, LA USA; [Yang, Lin] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing, Peoples R China; [Alyasova, Anna] Prevoljskiy Reg Med Ctr, Novgorod, Russia; [Ye, Dingwei] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; [Karpenko, Andrey] Leningrad Reg Oncol Dispensary, St Petersburg, Russia; [Alekseev, Boris] Moscow Hertzen Oncol Inst, Moscow, Russia; [Kowalyszyn, Ruben] Clin Viedma, Ctr Invest Clin, Viedma, Rio Negro, Argentina; [Karyakin, Oleg] Med Radiol Res Ctr, Obninsk, Russia; [Neron, Yeni] Ctr Pesquisas Oncol CEPON, Florianopolis, SC, Brazil; [Collins, La T.] Novartis Oncol, E Hanover, NJ USA; [Brechenmacher, Thomas] Novartis Pharma SAS, Rueil Malmaison, France; [Lin, Chinjune; Morgan, Liza] Novartis Oncol, E Hanover, NJ USA; [Motzer, Robert] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
会议名称：

BJU INTERNATIONAL
会议时间：
出版信息：

2016 年 118 卷 (18 - 19)

浏览次数：4  下载次数：0

浏览次数：4

下载次数：0

打印次数：0